Patents by Inventor Raymond A. Ng

Raymond A. Ng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACYLSULFONAMIDE KAT6A INHIBITORS
    Publication number: 20250136553
    Abstract: The present disclosure describes acylsulfonamide compounds of Formula (J), and pharmaceutically acceptable salts, compositions, methods, and uses thereof. Such compounds are believed to be therapeutically useful as KAT6A inhibitors particularly in the treatment and/or prevention of diseases and disorders mediated by KAT6A in a subject.
    Type: Application
    Filed: December 23, 2024
    Publication date: May 1, 2025
    Inventors: Brian R. Hearn, David C. Myles, Reena Chawla, David Yeghikyan, Chandregowda Venkateshappa, Susanta Samajdar, Kalisankar Bera, Suraj Tatyasaheb Gore, Raymond A. Ng
  • 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
    Patent number: 9120830
    Abstract: The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: June 27, 2014
    Date of Patent: September 1, 2015
    Assignee: Janssen Pharmaceutica NV
    Inventors: Vernon C Alford, Jr., James C Lanter, Raymond A Ng
  • NOVEL 2-SUBSTITUTED BENZIMIDAZOLES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)
    Publication number: 20140309261
    Abstract: The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: June 27, 2014
    Publication date: October 16, 2014
    Inventors: Vernon C. Alford, JR., James C. Lanter, Raymond A. Ng
  • 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
    Patent number: 8802865
    Abstract: The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: October 1, 2013
    Date of Patent: August 12, 2014
    Assignee: Janssen Pharmaceutica, NV
    Inventors: Vernon C Alford, Jr., James C Lanter, Raymond A Ng
  • NOVEL 2-SUBSTITUTED BENZIMIDAZOLES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)
    Publication number: 20140031317
    Abstract: The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: October 1, 2013
    Publication date: January 30, 2014
    Applicant: Janssen Pharmaceutica, NV
    Inventors: Vernon C Alford, JR., James C. Lanter, Raymond A. Ng
  • 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
    Patent number: 8575206
    Abstract: The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: March 17, 2011
    Date of Patent: November 5, 2013
    Assignee: Janssen Pharmaceutica, NV
    Inventors: Vernon C. Alford, Jr., James C. Lanter, Raymond A. Ng
  • NOVEL 2-SUBSTITUTED BENZIMIDAZOLES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)
    Publication number: 20110166102
    Abstract: The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: March 17, 2011
    Publication date: July 7, 2011
    Inventors: Vernon C. ALFORD, JR., James C. LANTER, Raymond A. NG
  • 2-substituted benzimidazoles as selective androgen receptor modulators (SARMS)
    Patent number: 7932399
    Abstract: The present invention is directed to a novel 2-substituted benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: January 23, 2007
    Date of Patent: April 26, 2011
    Assignee: Janssen Pharmaceutica NV
    Inventors: Vernon C. Alford, Jr., James C. Lanter, Raymond A. Ng, Zhihua Sui
  • Cyclohexyl derivatives as selective estrogen receptor modulators
    Patent number: 7183445
    Abstract: The present invention is directed to novel cyclohexyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and diseases mediated by an estrogen receptor.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: February 27, 2007
    Assignee: Janssen Pharmaceutica N.V
    Inventors: Nareshkumar F. Jain, Mark J. Macielag, William V. Murray, Raymond A. Ng, Zhihua Sui